NEW YORK (GenomeWeb) – GeneNews today said that it will receive total proceeds of roughly C$1.4 million (US$1.1 million) from the exercise of warrants.

The Canadian molecular diagnostics firm said that 5,736,916 share purchase warrants, exercisable into around 1 million shares of common stock have been exercised. The exercise price was C$1.44.

GeneNews didn't disclose its intended use for the proceeds.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

What happens to scientific papers when certain journals are no longer published? Some scientists are trying to make sure they don't disappear forever.

A study in Microbiome finds that heavy drinkers have an unhealthy mix of bacteria in their mouths.

Doctors and patients are still trying to figure out what role at-home genetic testing should play in healthcare, Newsweek says.

In Genome Research this week, mismatch repair deficiency in C. elegans, retracing transcriptions start site evolution in the human genome, and more.